checkAd

     201  0 Kommentare Appendix 4C Quarterly Activity Report for Quarter Ended June 30, 2023 - Seite 3

    Release authorized by the Chief Executive.

    Lesen Sie auch

    For more information, please contact:

    Corporate Communications / Investors Media
    Paul Hughes BlueDot Media
    T: +61 3 9639 6036 Steve Dabkowski
    E: investors@mesoblast.com T: +61 419 880 486
      E: steve@bluedot.net.au
       
      Rubenstein
      Tali Mackay
      E: tmackay@rubenstein.com
       

    Seite 3 von 3



    globenewswire
    0 Follower
    Autor folgen
    RSS-Feed abonnieren

    Weitere Artikel des Autors


    Verfasst von globenewswire
    2 im Artikel enthaltene WerteIm Artikel enthaltene Werte
    Appendix 4C Quarterly Activity Report for Quarter Ended June 30, 2023 - Seite 3 NEW YORK, July 30, 2023 (GLOBE NEWSWIRE) - Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, today provided an activity report for the fourth quarter ended June 30, 2023. …